Global partnership to make available 120 million affordable, quality COVID-19 rapid tests for low- and middle-income countries

Imported from official source

Alert

Safety Classified by Officially

  • A full access package includes WHO policy guidance on the use of antigen-based rapid diagnostic tests, manufacturer volume guarantees for low and middle-income countries,  catalytic funding to assist governments to deploy the tests and an initial US$50 million procurement fund
  • Several rapid, point-of-care antigen tests are being assessed by WHO for Emergency Use Listing (EUL)
  • Agreements between the Bill & Melinda Gates Foundation and test manufacturers Abbott and SD Biosensor make available innovative tests priced at a maximum of US$5 for low- and middle-income countries (LMICs)
  • The Global Fund commits an initial US$50 million to enable countries to purchase the new tests, with the first orders expected to be placed this week
  • Expedited market introduction of these tests in multiple LMICs is being supported through the Africa Centres for Disease Control and Prevention (Africa CDC), Unitaid, FIND, CHAI, and their partners
  • This is the latest move from the Access to COVID-19 Tools (ACT) Accelerator to develop, procure and distribute critical new tools to fight the pandemic; new tests are urgently needed to meet the huge unmet needs for testing worldwide 
  • A set of agreements to make available, for low and middle-income countries, affordable, high-quality COVID-19 antigen rapid tests were today announced by the Access to COVID-19 Tools (ACT) Accelerator. Organizations involved in the milestone agreement include the Africa Centres for Disease Control and Prevention (Africa CDC), the Bill & Melinda Gates Foundation, the Clinton Health Access Initiative (CHAI), the Foundation for Innovative New Diagnostics (FIND), the Global Fund, Unitaid, and the World Health Organization (WHO).

    This is an extract. The publication continues at the source.

    © World Health Organization. Licence: CC BY-NC-SA 3.0 IGO. Licence

    Read the original at the source: https://www.who.int/news/item/28-09-2020-global-partnership-to-make-available-120-million-affordable-quality-covid-19-rapid-tests-for-low--and-middle-income-countries

    Officially imported this from World Health Organization’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

    Provenance

    Organization
    World Health Organization — imported from official source
    Official source
    https://www.who.int/rss-feeds/news-english.xml RSS
    Imported
    November 03, 2026 00:02
    Versions
    1 recorded
    Identity
    urn:uuid:4d60f976-c9b7-4122-b36e-e8933980bbaf

    Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.